2020International Journal of Nursing Science Practice and ResearchRequires access

The Rarest Disease of Indian Community: Ocular Tuberculosis

Kavita Verma, Nitasha Sharma

Open publisher page 0 citations

Abstract

Tuberculosis is an ancient disease and we can find its description in the ancient Buddhist and Chinese writings. Ocular tuberculosis is an extrapulmonary mycobacterial infection with variable manifestations. Mycobacterium tuberculosis is a gram-positive, acid-fast bacillus (AFB) which spreads from person to person through airborne droplets. Prevalence of ocular tuberculosis in India is 0.4–9.8%. The term “ocular TB” describes an infection by the M. tuberculosis species that can affect any part of the eye (intraocular, superficial, or surrounding the eye), with or without systemic involvement. “Secondary ocular TB” is defined as ocular involvement as a result of seeding by hematogenous spread from a distant site or direct invasion by contiguous spread from adjacent structures, like the sinus or cranial cavity. Standard anti-TB treatment (ATT) 6 months of therapy based on WHO recommendations for first 8 weeks is Rifampin, Isoniazid, Ethambutol and Pyrazinamide and for next 18 weeks is Rifampin and Isoniazid.

About this research paper

What this paper is about

Tuberculosis is an ancient disease and we can find its description in the ancient Buddhist and Chinese writings. Ocular tuberculosis is an extrapulmonary mycobacterial infection with variable manifestations. Mycobacterium tuberculosis is a gram-positive, acid-fast bacillus (AFB) which spreads from person to person through airborne droplets. Prevalence of ocular tuberculosis in India is 0.4–9.8%. The term “ocular TB” describes an infection by the M. tuberculosis species that can affect any part of the eye (intraocular, superficial, or surrounding the eye), with or without systemic involvement. “Secondary ocular TB” is defined as ocular involvement as a result of seeding by hematogenous spread from a distant site or direct invasion by contiguous spread from adjacent structures, like the sinus or cranial cavity. Standard anti-TB treatment (ATT) 6 months of therapy based on WHO recommendations for first 8 weeks is Rifampin, Isoniazid, Ethambutol and Pyrazinamide and for next 18 weeks is Rifampin and Isoniazid.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Tuberculosis is an ancient disease and we can find its description in the ancient Buddhist and Chinese writings. Ocular tuberculosis is an extrapulmonary mycobacterial infection with variable manifestations. Mycobacterium tuberculosis is a gram-positive, acid-fast bacillus (AFB) which spreads from person to person through airborne droplets. Prevalence of ocular tuberculosis in India is 0.4–9.8%. The term “ocular TB” describes an infection by the M. tuberculosis species that can affect any part of the eye (intraocular, superficial, or surrounding the eye), with or without systemic involvement. “Secondary ocular TB” is defined as ocular involvement as a result of seeding by hematogenous spread from a distant site or direct invasion by contiguous spread from adjacent structures, like the sinus or cranial cavity. Standard anti-TB treatment (ATT) 6 months of therapy based on WHO recommendations for first 8 weeks is Rifampin, Isoniazid, Ethambutol and Pyrazinamide and for next 18 weeks is Rifampin and Isoniazid.

Key concepts: Ethambutol, Tuberculosis, Isoniazid, Pyrazinamide, Mycobacterium tuberculosis, Medicine, Disease, Dermatology

Related papers

Back to paper searchBrowse research topicsOriginal source
The Rarest Disease of Indian Community: Ocular Tuberculosis — Research Paper | ScholarLens